Study of Kinase Inhibitor WP1066 on the STAT3/JAK2 of Prostate Stromal Cells
Abstract
To study the role of JAK2 signaling pathway in prostate stromal cells and the effect of inhibitor WP1066 on its expression. Methods The phosphorylation of JAK2 and STAT3 in prostate tissues of patients with benign prostatic hyperplasia (ВНР) (?/ = 4) and severe histological prostatitis (HP) plus BPH (;/ = 4) was tested by using Western blot to verify the activation of their mediated signaling pathway. Kinase inhibitor WP1066 was added to prostate stromal cells to detect inhibition of the JAK2 and STAT3 activation launched by IL-6. Results JAK2 phosphorylation level (pJAK2) was significantly increased in the patients with severe HP plus BPH, and the expression of JAK2 or STAT3 was not decreased in WP1066 treatment cells. However, neither phosphorylation in JAK2 nor STAT3 was able to be detected in the cells treated with WP1066 or WP1066 + IL-6, indicating that the signaling pathway of JAK2-STAT3 was inhibited. Conclusion JAK/STAT signaling pathway is activated in patients with severe HP plus BPH *but could be inhibited by WP1066.
Keywords: Benign prostatic hyperplasia, Kinase inhibitor, Phosphorylation, Activation
Full Text:
PDFReferences
COLADCVvelAzquez J. MAILLOUX-SALINAS p. MEDINA-CONTRERAS J, et al. Effect of Serenoa repens on oxidative stress, inflammatory and growth factors in obese wistar rats with benign prostatic hyperplasia. Phytother Res. 2015,29(10): 1525-1531.
HOLMSTROM F, SHIMIZU S, SHIMIZU T, et al. Protective effect of hydroxyfasudil, a Rho kinase inhibitor, on ventral prostatic hyperplasia in the spontaneously hypertensive rat. Prostate,2015, 75(15); 1774-1782.
FU XT, DAI Z, SONG K, et al. Macrophage-secreted IL-8 induces epithelial-mesenchymal transition in hepatocellular carcinoma cells by activating the J AK2/STAT3/Snail pathway. Int J Oncol,2015,46(2) ;587-596.
ZHOUJ, YI L, OUYANG Q. et al. Neurotensin signaling regulates stem-like traits of glioblastoma stem cells through activation of IL-8/CXCR1/STAT3 pathway. Cell Signal, 2011,26(12):2896-2902.
JORVIG JE, CHAKRABORTY A. Zerumbone inhibits growth of hormone refractory prostate cancer cells by inhibiting JAK2/STAT3 pathway and increases paclitaxel sensitivity. Anticancer Drugs,2015,26(2): 160-166.
CHO KH, CHOI MJ. JEONG KJ, et al. A ROS/STAT3/ HIF-la signaling cascade mediates EGF-induced TWISTl expression and prostate cancer cell invasion. Prostate.2014 ,4 (5):528-536.
YUAN X, DU J. HUA S. et al. Suppression of autophagy augments the radiosensitizing effects of STAT3 inhibition on humanglioma cells. P3xp Cell Res,2015.330(2):267-276.
LIU C, LOU W, ARMSTRONG C, et al. Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibition. Prostate,2015,75(13): 1341-1353.
PALMIERI C, LEAN FZ, AKTER SH, et al. A retrospective analysis of 111 canine prostatic samples: histopathological findings and classification. Res Vet Sci, 2014.97(3):568-573 о
CORVIN S, BOSCH ST, EDER I, et al. Videoimaging of prostatic stromal-cell contraction: an in zritro model for studying drug effects. Prostate, 1998,37(4) ; 1209-12140
JUNG SN, SHIN DS, KIM HN, et al . Sugiol inhibits STAT3 activity via regulation of transketolase and ROS- mediated ERK activation in DU 145 prostate carcinoma cells. Biochem Pharmacol ,2015 ,97(1); 38-50.
HOSSAIN DM, PAL SK. MOREIRA D. et al. TLR9- Targeted STAT3 silencing abrogates immunosuppressive activity of myeloid-derived suppressor cells from prostate cancer patients. Clin Cancer Res,2015,21 (16):3771-3782.
ELKS CM, ZHAO P, GRANT RW, et al. Loss of oncostatin M signaling in adipocytes induces insulin resistance and adipose tissue inflammation in vivo. J Biol Chem, 2016, 291 (33):17066-17076.
Refbacks
- There are currently no refbacks.